SCHEDULE 13G

Company

Niagen Bioscience, Inc.

Filed

August 31, 2015

Accession Number

0001415889-15-002928

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →